Tasuku Yamamoto, Jakub Sroubek, Koji Higuchi, Justin Lee, Mandeep Bhargava, Bryan Baranowski, Thomas Callahan, Mina Chung, Roy Chung, Thomas Dresing, Ayman Hussein, Mohamed Kanj, Arshneel Kochar, Arwa Younis, David Martin, Walid Saliba, Tyler Taigen, Niraj Varma, Oussama Wazni, Pasquale Santangeli
Critical ISS-VT sites colocalize with areas of significant (>100 ms) DCT. Areas of septal DCT >50% of the RV paced QRS duration subtend the majority of the ISS-VT termination sites and can represent a novel and more specific target for septal substrate modification in this challenging population.
BACKGROUND: Delayed trans-septal conduction time (DCT) accurately identifies intramural septal substrate (ISS) in non-ischemic cardiomyopathy (NICM). The relationship between DCT areas and critical ISS-ventricular tachycardia (VT) sites is unknown.
OBJECTIVE: To assess the relationship between DCT areas and critical ISS-VT sites in NICM.
METHODS: We included consecutive patients with NICM and ISS defined by: 1) confluent septal areas of low unipolar voltage (<8.3 mV) with normal/minimal bipolar abnormalities; 2) trans-septal DCT (>40 ms by pacing the basal RV septum). Critical ISS-VT sites were identified with activation, entrainment and/or pace mapping and corroborated by VT termination during ablation (stable VT) and/or lack of VT reinducibility following ablation (unstable VT).
RESULTS: Fifty-six distinct ISS-VTs in 28 patients (69±11 years, EF 35±11%) were analyzed. Of these, 17 ISS-VTs were stable and terminated with ablation. Targeted ISS areas leading to VT non-inducibility or VT termination had a median DCT of 106 ms [IQR: 89-142] and 146 ms [130-192], respectively. Sixteen out of 17 (94%) termination sites had DCT >50% of the RV paced QRS, with 35% showing only systolic local potentials during VT confirming primarily intramural circuits. Elimination of the targeted ISS-VT was achieved in 96% of cases, with non-inducibility of any VTs in 79%.
CONCLUSIONS: Critical ISS-VT sites colocalize with areas of significant (>100 ms) DCT. Areas of septal DCT >50% of the RV paced QRS duration subtend the majority of the ISS-VT termination sites and can represent a novel and more specific target for septal substrate modification in this challenging population.